{"id":409308,"date":"2021-01-06T07:34:14","date_gmt":"2021-01-06T12:34:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=409308"},"modified":"2021-01-06T07:34:14","modified_gmt":"2021-01-06T12:34:14","slug":"optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/","title":{"rendered":"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021"},"content":{"rendered":"
\n

ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) — OptimizeRx\u00a0Corp.<\/u><\/a>\u00a0(Nasdaq: OPRX), a leading\u00a0provider of digital health solutions for life science companies, physicians and patients, has been invited to present at H.C. Wainwright\u2019s BioConnect Conference being held virtually on January 11-14, 2021.<\/p>\n

The company\u2019s presentation will be available on-demand via the H.C. Wainwright conference portal here<\/a> and in the investor relations section at investors.optimizerx.com<\/a> beginning at 6:00 a.m. Eastern time on Monday, January 11.<\/p>\n

OptimizeRx CEO, William Febbo, will participate in virtual one-on-one meetings with institutional analysts and investors throughout the conference.<\/p>\n

Management will discuss the company\u2019s expanding addressable market due to the launch of new digital health solutions, and how an increasing number of enterprise-level, recurring revenue engagements are keeping the company on track for another year of record growth.<\/p>\n

OptimizeRx generated $34.3 million in trailing 12-month revenue ended September 30, 2020, up 44% compared to the same year-ago period.<\/p>\n

Register for the conference here<\/a>. To schedule a one-on-one meeting, please contact your H.C. Wainwright representative. For any questions about\u00a0OptimizeRx, please contact\u00a0Ron Both\u00a0of CMA at (949) 432-7557 or submit your request\u00a0here<\/a>.<\/p>\n

\n About H.C. Wainwright<\/strong>
\n
H.C. Wainwright is a full\u2010service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions.\u00a0\u00a0H.C. Wainwright & Co. also provides research and sales and trading services to institutional investors.\u00a0According to Sagient Research Systems, H.C. Wainwright\u2019s team is ranked as the #1 Placement Agent in terms of aggregate CMPO (confidentially marketed public offering), RD (registered direct offering) and PIPE (private investment in public equity) executed cumulatively since 1998. For more information about H.C. Wainwright, visit www.hcwco.com<\/a>.<\/p>\n

About\u00a0OptimizeRx<\/strong>\u00a0
OptimizeRx\u00a0is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary network, the\u00a0OptimizeRx\u00a0digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care, to retail pharmacy, through mobile patient engagement.\u00a0\u00a0<\/p>\n

For more information, follow the company on\u202fTwitter<\/u><\/a>,\u202fLinkedIn<\/u><\/a>\u202for visit\u202fwww.optimizerx.com<\/u><\/a>.\u202f\u00a0<\/p>\n

\n Important Cautions Regarding Forward Looking Statements<\/strong>\u00a0
This\u00a0press\u00a0release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words ‘estimate,’ ‘possible’ and ‘seeking’ and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could\u00a0differ\u00a0materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.\u00a0<\/p>\n

\n OptimizeRx\u202fContact<\/strong>\u202f\u00a0
Doug Baker, CFO\u00a0
Tel (248) 651-6568 (x807)\u00a0
dbaker@optimizerx.com<\/u><\/a>\u202f\u00a0
\u202f\u00a0
Media Relations Contact<\/strong>\u202f\u00a0
Maira\u00a0Alejandra, Media Relations Manager\u00a0
Tel (754) 245-7070\u202f\u00a0
malejandra@optimizerx.com<\/u><\/a>\u202f<\/u>\u00a0
\u202f\u00a0
Investor Relations Contact<\/strong>\u202f\u00a0
Ron Both, CMA\u202f\u00a0
Tel (949) 432-7557\u202f\u00a0
oprx@cma.team<\/u><\/a>\u00a0\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) — OptimizeRx\u00a0Corp.\u00a0(Nasdaq: OPRX), a leading\u00a0provider of digital health solutions for life science companies, physicians and patients, has been invited to present at H.C. Wainwright\u2019s BioConnect Conference being held virtually on January 11-14, 2021. The company\u2019s presentation will be available on-demand via the H.C. Wainwright conference portal here and in the investor relations section at investors.optimizerx.com beginning at 6:00 a.m. Eastern time on Monday, January 11. OptimizeRx CEO, William Febbo, will participate in virtual one-on-one meetings with institutional analysts and investors throughout the conference. Management will discuss the company\u2019s expanding addressable market due to the launch of new digital health solutions, and how an increasing number of enterprise-level, recurring revenue engagements are keeping the … <\/p>\n

Continue reading “OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-409308","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nOptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) — OptimizeRx\u00a0Corp.\u00a0(Nasdaq: OPRX), a leading\u00a0provider of digital health solutions for life science companies, physicians and patients, has been invited to present at H.C. Wainwright\u2019s BioConnect Conference being held virtually on January 11-14, 2021. The company\u2019s presentation will be available on-demand via the H.C. Wainwright conference portal here and in the investor relations section at investors.optimizerx.com beginning at 6:00 a.m. Eastern time on Monday, January 11. OptimizeRx CEO, William Febbo, will participate in virtual one-on-one meetings with institutional analysts and investors throughout the conference. Management will discuss the company\u2019s expanding addressable market due to the launch of new digital health solutions, and how an increasing number of enterprise-level, recurring revenue engagements are keeping the … Continue reading "OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-06T12:34:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021\",\"datePublished\":\"2021-01-06T12:34:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/\"},\"wordCount\":580,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/\",\"name\":\"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=\",\"datePublished\":\"2021-01-06T12:34:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/","og_locale":"en_US","og_type":"article","og_title":"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 - Market Newsdesk","og_description":"ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) — OptimizeRx\u00a0Corp.\u00a0(Nasdaq: OPRX), a leading\u00a0provider of digital health solutions for life science companies, physicians and patients, has been invited to present at H.C. Wainwright\u2019s BioConnect Conference being held virtually on January 11-14, 2021. The company\u2019s presentation will be available on-demand via the H.C. Wainwright conference portal here and in the investor relations section at investors.optimizerx.com beginning at 6:00 a.m. Eastern time on Monday, January 11. OptimizeRx CEO, William Febbo, will participate in virtual one-on-one meetings with institutional analysts and investors throughout the conference. Management will discuss the company\u2019s expanding addressable market due to the launch of new digital health solutions, and how an increasing number of enterprise-level, recurring revenue engagements are keeping the … Continue reading \"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-06T12:34:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021","datePublished":"2021-01-06T12:34:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/"},"wordCount":580,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/","name":"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=","datePublished":"2021-01-06T12:34:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTA1MSMzOTA1ODcwIzIwNDk4ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference-on-january-11-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=409308"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/409308\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=409308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=409308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=409308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}